Cav2.1 channelopathies and genetic approaches for investigatings Cav2.1 channel function and dysfunction

Calcium Signaling

Volumn , Issue , 2012, Pages 149-158

  Takahashi, Eiki ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Cav2.1; Channelopathy; Epilepsy; Episodic ataxia type 2 (EA2); Familial hemiplegic migraine type 1 (FMH1); Mouse model; Spinocerebellar ataxia type 6 (SCA6); Synaptic transmission

Indexed keywords

EID: 84865663991     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (48)

1. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002. 8:136-142.
2. 2+ channels and their role in neurotransmitter release. Cell Calcium. 1998. 24:307-323.
3. 2+ channels and snare proteins in neurotransmitter release. Ann. NY Acad. Sci. 1999. 868:144-159.
4. 2+ channel regulation and presynaptic plasticity. Neuron. 2008. 59:882-901.
5. Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001. 345:17-24.
6. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN, Copeland NG, Jenkins NA. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell. 1996. 87:607-617.
7. Fletcher CF, Tottene A, Lennon VA, Wilson SM, Dubel SJ, Paylor R, Hosford DA, Tessarollo L, McEnery MW, Pietrobon D, Copeland NG, Jenkins NA. Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. Faseb J. 2001. 15:1288-1290.
8. Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet. 2005. 6:743-755.
9. Guerin AA, Feigenbaum A, Donner EJ, Yoon G. Stepwise developmental regression associated with novel CACNA1A mutation. Pediatr Neurol. 2008. 39:363-364.
10. Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, Veneziano L, Fellin T, Spadaro M, Stauderman K, Williams M, Volsen S, Ophoff R, Frants R, Jodice C, Frontali M, Pietrobon D. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet. 2001. 68:759-764.
11. Hobom M, Dai S, Marais E, Lacinova L, Hofmann F, Klugbauer N. Neuronal distribution and functional characterization of the calcium channel alpha2delta-2 subunit. Eur J Neurosci. 2000. 124:1217-1226.
12. Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R, Kullmann DM Hanna MG. Dysfunction of the brain calcium channel Cav2. 1 in absence epilepsy and episodic ataxia. Brain. 2004. 127:2682-2692.
13. Inchauspe CG, Forsythe ID, Uchitel OD. Changes in synaptic transmission properties due to the expression of N-type calcium channels at the calyx of Held synapse of mice lacking P/Q-type calcium channels. J Physiol. 2007. 584:835-851.
14. Ishikawa K, Fujigasaki H, Saegusa H, Ohwada K, Fujita T, Iwamoto H, Komatsuzaki Y, Toru S, Toriyama H, Watanabe M, Ohkoshi N, Shoji S, Kanazawa I, Tanabe T, Mizusawa H. Abundant expression and cytoplasmic aggregations of alpha1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum Mol Genet. 1999. 8:1185-1193.
15. Jahn R and Scheller RH. SNAREs-engines for membrane fusion. Nat Rev Mol Cell Biol. 2006. 7:631-643.
16. Jarvis SE and Zamponi GW. Trafficking and regulation of neuronal voltage-gated calcium channels. Curr Opin Cell Biol. 2007. 19:474-482.
17. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology. 2004. 62:17-22.
18. Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain. 2007. 130:2484-2493
19. Jiang Y, Ruta V, Chen J, Lee A, MacKinnon R. The principle of gating charge movement in a voltage-dependent K+ channel. Nature. 2003. 423:42-48.
20. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F, Ophoff RA, Frants RR, Frontali M. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet. 1997. 6:1973-1978.
21. Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM Hanna MG. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet. 2001. 358:801-807.
22. Kors EE, Terwindt GM, Vermeulen FL, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg AM, Haan J, Frants RR, Ferrari MD. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol. 2001. 49:753-760.
23. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994. 117:199-210
24. Miki T, Zwingman TA, Wakamori M, Lutz CM, Cook SA, Hosford DA, Herrup K, Fletcher CF, Mori Y, Frankel WN, Letts VA. Two novel alleles of tottering with distinct Cav2. 1 calcium channel neuropathologies. Neuroscience. 2008. 155:31-44.
25. 2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)). J Neurosci. 2000. 20:5654-5662.
26. Oda S. The observation of rolling mouse Nagoya (rol), a new neurological mutant, and its maintenance. Exp Anim. 1973. 22:281-286.
27. 2+ channel gene CACNL1A4. Cell. 1996. 87:543-552.
28. Pietrobon D. Calcium channels and channelopathies of the central nervous system. Mol Neurobiol. 2002. 25:31-50.
29. Pietrobon D. Cav2. 1 channelopathies. Pflugers Arch. 2010. 460:375-393.
30. Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007. 4:267-273.
31. Takahashi H, Ishikawa K, Tsutsumi T, Fujigasaki H, Kawata A, Okiyama R, Fujita T, Yoshizawa K, Yamaguchi S, Tomiyasu H, Yoshii F, Mitani K, Shimizu N, Yamazaki M, Miyamoto T, Orimo T, Shoji S, Kitamura K, Mizusawa H. A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6. J Hum Genet. 2004. 49:256-264.
32. 2+ channels: four subtypes of alpha 1-and beta-subunits in developing and mature rat brain. Brain Res Mol Brain Res. 1995. 30:1-16.
33. Tedford HW and Zamponi GW. Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev. 2006. 58:837-862.
34. Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D. Specific kinetic alterations of human Cav2. 1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem. 2005. 280:17678-17686.
35. 2+ channels. Proc Natl Acad Sci USA. 2003. 100:3491-3496.
36. Vadlamudi L, Scheffer IE, Berkovic SF. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2003. 74:1359-1361.
37. van de Ven RC, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AM, Ferrari MD. Genetic models of migraine. Archives of neurology. 2007. 64:643-646.
38. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, van de Ven RC, Tottene A, van der Kaa J, Plomp JJ, Frants RR, Ferrari MD. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004. 41:701-710.
39. van den Maagdenberg AM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, Barrett CF, Gherardini L, van de Ven RC, Todorov B, Broos LA, Tottene A, Gao Z, Fodor M, De Zeeuw CI, Frants RR, Plesnila N, Plomp JJ, Pietrobon D, Ferrari MD. High CSD susceptibility and migraine-associated symptoms in Cav2. 1 S218L mice. Ann Neurol. 2010. 67:85-98.
40. 2+ channels: role in channel function. Trends Neurosci. 1998. 21:148-154.
41. Watase K, Barrett CF, Miyazaki T, Ishiguro T, Ishikawa K, Hu Y, Unno T, Sun Y, Kasai S, Watanabe M, Gomez CM, Mizusawa H, Tsien RW, Zoghbi HY. Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant Cav2. 1 channels. Proc Natl Acad Sci USA. 2008. 105:11987-1199.
42. Weiss N, Sandoval A, Felix R, Van den Maagdenberg A, De Waard M. The S218L familial hemiplegic migraine mutation promotes deinhibition of Cav2. 1 calcium channels during direct G-protein regulation. Pflugers Arch. 2008. 457:315-326.
43. Williams ME, Marubio LM, Deal CR, Hans M, Brust PF, Philipson LH, Miller RJ, Johnson EC, Harpold MM, Ellis SB. Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. J Biol Chem. 1994. 269:22347-22357.
44. Xie G, Clapcote SJ, Nieman BJ, Tallerico T, Huang Y, Vukobradovic I, Cordes SP, Osborne LR, Rossant J, Sled JG, Henderson JT, Roder JC. Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes Brain Behav. 2007. 6:717-727.
45. Yue Q, Jen JC, Nelson SF, Baloh RW. Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet. 1997. 61:1078-1087.
46. Yokoyama CT, Myers SJ, Fu J, Mockus SM, Scheuer T, Catterall WA. Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interaction site. Mol Cell Neurosci. 2005. 28:1-17.
47. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997. 15:62-69.
48. Zwingman TA, Neumann PE, Noebels JL, Herrup K. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J Neurosci. 2001. 21:1169-1178.